China Resources Holdings, a China-Hong Kong state-owned multi-sector conglomerate, will join with Charoen Pokphand Group of Bangkok, a Thai conglomerate, to launch the $300 million CR-CP Life Science Fund. The two general partners will put a combined $150 million of their own money into the fund and raise another $150 million from global life science investors. The fund, based in Hong Kong, intends to invest in companies that are developing innovative drugs and cell therapies, medical devices and healthcare AI.
Source: China Biotoday
